Deveron Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Deveron heeft een totaal eigen vermogen van CA$29.2M en een totale schuld van CA$44.0M, wat de schuld-eigenvermogensverhouding op 150.9% brengt. De totale activa en totale passiva bedragen respectievelijk CA$102.5M en CA$73.3M.

Belangrijke informatie

150.9%

Verhouding schuld/eigen vermogen

CA$43.99m

Schuld

Rente dekkingsratio	n/a
Contant	CA$1.09m
Aandelen	CA$29.15m
Totaal verplichtingen	CA$73.30m
Totaal activa	CA$102.45m

Recente financiële gezondheidsupdates

Is Deveron (CVE:FARM) A Risky Investment?

Nov 24

Is Deveron (CVE:FARM) Using Too Much Debt?

Aug 23

Recent updates

Deveron Corp. (CVE:FARM) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jun 20

Deveron Corp. (CVE:FARM) Might Not Be As Mispriced As It Looks After Plunging 26%

May 03

CA$1.33: That's What Analysts Think Deveron Corp. (CVE:FARM) Is Worth After Its Latest Results

Nov 25

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CA$5.6M ) van FARM } dekken niet de korte termijn passiva ( CA$14.5M ).

Langlopende schulden: De kortetermijnactiva van FARM ( CA$5.6M ) dekken de langetermijnschulden ( CA$58.8M ) niet.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 147.1% ) FARM wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van FARM is de afgelopen 5 jaar gestegen van 0% naar 150.9%.

Balans

Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: Terwijl het verlieslatende FARM voldoende cash runway heeft voor meer dan 3 jaar, als het zijn huidige positieve vrije kasstroom-niveau behoudt.

Voorspelling contante baan: FARM is verlieslatend, maar heeft voldoende kasmiddelen voor meer dan 3 jaar, zelfs bij een positieve vrije kasstroom die met 22.6 % per jaar krimpt.

Deveron Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Is Deveron (CVE:FARM) A Risky Investment?

Is Deveron (CVE:FARM) Using Too Much Debt?

Recent updates

Less than half of directors are independent

Deveron Corp. announced that it has received CAD 3.13581 million in funding

Deveron Corp. announced that it expects to receive CAD 3 million in funding

New minor risk - Shareholder dilution

Deveron Corp. (CVE:FARM) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Third quarter 2024 earnings released: CA$0.025 loss per share (vs CA$0.042 loss in 3Q 2023)

New major risk - Market cap size

Deveron Corp. to Report Q3, 2024 Results on May 28, 2024

Deveron Corp., Annual General Meeting, Jul 25, 2024

Deveron Corp. (CVE:FARM) Might Not Be As Mispriced As It Looks After Plunging 26%

Deveron Corp. announced that it has received CAD 0.575 million in funding

Second quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.03 profit in 2Q 2023)

Deveron Corp. to Report Q2, 2024 Results on Feb 21, 2024

Deveron Passes 2-Stage Pilot and Onboards New Pfas Enterprise Customer

New major risk - Share price stability

Investors Continue Waiting On Sidelines For Deveron Corp. (CVE:FARM)

Independent Non Executive Chairman recently bought CA$204k worth of stock

Is Deveron (CVE:FARM) A Risky Investment?

Deveron Corp. to Report Q1, 2024 Results on Nov 21, 2023

Full year 2023 earnings released: CA$0.19 loss per share (vs CA$0.12 loss in FY 2022)

Deveron Corp. to Report Q4, 2023 Results on Oct 26, 2023

Deveron Corp. announced that it expects to receive CAD 2 million in funding

Deveron Corp. Announces CFO Changes

Deveron Corp. Provides Revenue Guidance for the Fourth Quarter Ending June 30, 2023

Deveron Corp. Provides Revenue Guidance for the Fourth Quarter Ending June 30, 2023

Is Deveron (CVE:FARM) Using Too Much Debt?

Price target decreased by 14% to CA$0.92

First quarter 2023 earnings released: CA$0.042 loss per share (vs CA$0.037 loss in 1Q 2022)

Deveron Corp. to Report Q1, 2023 Results on May 30, 2023

Deveron Corp., Annual General Meeting, Jun 27, 2023

Director recently bought CA$750k worth of stock

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Deveron Corp. Announces Retirement of Jim Pirie from Board of Directors, Effective January 1, 2023

Consensus EPS estimates fall by 30%

Independent Non Executive Chairman exercised options to buy CA$110k worth of stock.

CA$1.33: That's What Analysts Think Deveron Corp. (CVE:FARM) Is Worth After Its Latest Results

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Deveron Corp. Appoints Tim Close as New Board Member

Independent Non Executive Chairman exercised options to buy CA$204k worth of stock.

No longer forecast to breakeven

Deveron Corp. to Report Q3, 2022 Results on Nov 21, 2022

Deveron Corp. (TSXV:FARM) completed the acquisition of Assets of Frontier Labs Inc.

Deveron Corp. announced that it has received CAD 2.7 million in funding from Coeli Wealth Management AB

Deveron Corp. announced that it has received CAD 2.7 million in funding from Coeli Wealth Management AB

Deveron Corp. (TSXV:FARM) has completed a Letter of Intent to acquire Assets of Frontier Labs Inc on September 20, 2022.

Deveron Corp. announced that it expects to receive $1.5 million in funding from Coeli Wealth Management AB

No longer forecast to breakeven

Deveron Corp. to Report Q2, 2022 Results on Aug 22, 2022

Deveron Corp. (TSXV : FARM) completed the acquisition of Assets of Agri-Labs, Inc. for $1.2 million.

Deveron Corp. (TSXV:FARM) acquired 67% stake in A&L Canada Laboratories Inc. from certain vendor shareholders including Greg Patterson, CEO of A&L.

Deveron Corp. (TSXV:FARM) acquired 67% stake in A&L Canada Laboratories Inc. from certain vendor shareholders including Greg Patterson, CEO of A&L.

Deveron Corp. announced that it has received CAD 10 million in funding

Deveron Corp. announced that it expects to receive CAD 10 million in funding

Deveron Corp. (TSXV:FARM) entered into a definitive agreement to acquire a 67% stake in A&L Canada Laboratories Inc. from certain vendor shareholders including Greg Patterson, CEO of A&L, for CAD 50.3 million.

Deveron Corp., Annual General Meeting, Jun 28, 2022

Deveron Corp. has completed a Composite Units Offering in the amount of CAD 10 million.

Deveron Corp. Launches of Its Agricultural Carbon Services Platform

Deveron Corp. (TSXV:FARM) entered into an agreement to acquire Assets of Agronomic Solutions, LLC. from Agronomic Solutions, LLC for $1.1 million.

Deveron Corp. (TSXV:FARM) completed the acquisition of assets of Stealth Ag Inc.

Deveron Corp. announced that it has received CAD 8.207583 million in funding

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse van de cashflow

Ontdek gezonde bedrijven